{"slideshow_credits": null, "snippet": "The alliance between the American and German companies is expected to strengthen Merck\u2019s oncology business in several important markets, including the United States.", "abstract": "The alliance between the American and German companies is expected to strengthen Merck\u2019s oncology business in several important markets, including the United States.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Chad", "role": "reported", "lastname": "BRAY", "rank": 1, "organization": ""}], "original": "By CHAD BRAY"}, "web_url": "http://dealbook.nytimes.com/2014/11/17/pfizer-to-pay-up-to-2-9-billion-in-cancer-drug-deal-with-merck-of-germany/", "lead_paragraph": null, "headline": {"main": "Pfizer to Pay up to $2.9 Billion in Cancer Drug Deal With Merck of Germany", "kicker": "DealBook"}, "_id": "5469cf1a38f0d8317bec19c2", "word_count": "426", "multimedia": [], "pub_date": "2014-11-17T05:32:21Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Germany", "name": "glocations", "rank": "1"}, {"value": "United States", "name": "glocations", "rank": "2"}, {"value": "Merck of Germany", "name": "organizations", "rank": "1"}, {"value": "Pfizer Inc", "name": "organizations", "rank": "2"}, {"value": "Cancer", "name": "subject", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2"}, {"value": "Medicine and Health", "name": "subject", "rank": "3"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "4"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}